- Report
- October 2023
- 146 Pages
Global
From €3763EUR$4,150USD£3,169GBP
- Report
- October 2023
- 146 Pages
Global
From €3763EUR$4,150USD£3,169GBP
- Report
- October 2023
- 146 Pages
Global
From €3763EUR$4,150USD£3,169GBP
From €3618EUR$3,990USD£3,047GBP
- Report
- June 2025
United States
From €3618EUR$3,990USD£3,047GBP
- Report
- June 2025
North America
From €3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Middle East
From €3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Asia Pacific
From €3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Global
From €3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Europe
From €3618EUR$3,990USD£3,047GBP
- Report
- June 2025
United Kingdom
From €3618EUR$3,990USD£3,047GBP
- Report
- June 2025
United Kingdom
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Europe
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Global
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
United States
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
North America
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Middle East
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- June 2025
Asia Pacific
From €1900EUR$2,095USD£1,600GBP
€3618EUR$3,990USD£3,047GBP
- Report
- February 2025
- 86 Pages
Brazil, China, India, ... Brazil, China, India, Russia
From €5436EUR$5,995USD£4,579GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more